Efficacy and Safety of the Atrial Septal Defect Closure for Patients with Absent or Malaligned Aortic Rim Using a Figulla Flex II Device Flared and Straddling Behind the Aorta

被引:2
|
作者
Kitano, Masataka [1 ,2 ,3 ]
Fujimoto, Kazuto [1 ]
Kato, Atsuko [1 ]
Kurosaki, Ken-ichi [1 ]
Shiraishi, Isao [1 ]
机构
[1] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Osaka, Japan
[2] Okinawa Prefectural Nanbu Med Ctr, Dept Pediat Cardiol, Haebaru, Okinawa, Japan
[3] Childrens Med Ctr, Haebaru, Okinawa, Japan
关键词
Atrial septal defect; catheter intervention; device embolization; cardiac erosion; conduction disorder; TRANSCATHETER CLOSURE; OCCLUDER DEVICES; CARDIAC EROSION; MANUFACTURER;
D O I
10.32604/CHD.2021.015308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Although transcatheter closure of atrial septal defect (ASD) is safe and effective for patients with sufficient rim, ASD patients with absent and/or malaligned aortic and/or superior rim have higher risks of device embolization and cardiac erosion. We have treated such high-risk patients using a Figulla Flex II (FFII) device shaped flared and straddling behind the aorta because this method would avoid such serious complications. However, its long-term efficacy and safety remain unclear. Therefore, the midterm efficacy and safety of this method were studied. Methods: We retrospectively evaluated the outcome of 47 consecutive patients with such rim (age 6-73 years, weight 17-75 kg, 31 females) treated with this method at our hospital between February 2016 and September 2019. To make the flared and straddling shape, we selected a FFII 4-6 mm larger than the balloon sizing diameter by stop-flow technique. We also studied the device shape, the disc pressure to the Valsalva wall and their changes over 6 months by transesophageal echocardiography. Results: All procedures were successful, and leakage disappeared within 1 year. During a mean follow up of 37 +/- 12 months, complications included a transient sinus node dysfunction and one I degrees atrioventricular block within 3 months. Whole device shape changed from bulky to thin: the device waist and thickness significantly decreased by around 1.5 mm and 3.5 mm, respectively (p < 0.05), but the two discs remained flared and straddling behind the aorta over 6 months; therefore, the disc edges seldom pressed the Valsalva wall perpendicularly, even though the inner plane of either disc often slightly pressed the wall. Conclusions: ASD closure using a FFII shaped flared and straddling behind the aorta is probably effective and safe for patients with absent and/or malaligned aortic and/or superior rim although requiring care for conduction disorders.
引用
收藏
页码:269 / 283
页数:15
相关论文
共 7 条
  • [1] Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex II compared with Amplatzer Septal Occluder
    Rie Nakayama
    Yoichi Takaya
    Teiji Akagi
    Nobuhisa Watanabe
    Takashi Miki
    Koji Nakagawa
    Norihisa Toh
    Hiroshi Ito
    Heart and Vessels, 2021, 36 : 704 - 709
  • [2] Efficacy and safety of atrial septal defect closure using Occlutech Figulla Flex II compared with Amplatzer Septal Occluder
    Nakayama, Rie
    Takaya, Yoichi
    Akagi, Teiji
    Watanabe, Nobuhisa
    Miki, Takashi
    Nakagawa, Koji
    Toh, Norihisa
    Ito, Hiroshi
    HEART AND VESSELS, 2021, 36 (05) : 704 - 709
  • [3] Pericardial tamponade due to erosion of a Figulla Flex II device after closure of an atrial septal defect
    Abe, Tadaaki
    Tsukano, Shinya
    Tosaka, Yuko
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 94 (07) : 1003 - 1005
  • [4] Feasibility of transcatheter closure for absent aortic rim in patients with atrial septal defect
    Takaya, Yoichi
    Akagi, Teiji
    Nakagawa, Koji
    Nakayama, Rie
    Miki, Takashi
    Toh, Norihisa
    Ito, Hiroshi
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (05) : 859 - 864
  • [5] Transcatheter closure of an atrial septal defect with high risk of erosion using a Figulla Flex II atrial septal defect occluder
    Tada N.
    Mizutani Y.
    Matsumoto T.
    Sakurai M.
    Ootomo T.
    Cardiovascular Intervention and Therapeutics, 2017, 32 (4) : 436 - 439
  • [6] A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects
    Kenny, Damien
    Eicken, Andreas
    Daehnert, Ingo
    Boudjemline, Younes
    Sievert, Horst
    Schneider, Martin B. E.
    Gori, Tommaso
    Hijazi, Ziyad M.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (02) : 316 - 321
  • [7] A case of infective endocarditis in an 8-year-old boy 3 months after transcatheter atrial septal defect closure using Figulla Flex II occluder
    Toyoshima, Yuka
    Tanaka, Toshikatsu
    Matsuhisa, Hironori
    CARDIOLOGY IN THE YOUNG, 2023, 33 (06) : 1030 - 1032